Adicet Bio, Inc.
ACET
$8.15
$0.040.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -29.55% | -18.75% | -14.55% | -7.14% | 5.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.13% | -4.31% | -5.81% | -1.49% | -2.69% |
| Operating Income | 10.13% | 4.31% | 5.81% | 1.49% | 2.69% |
| Income Before Tax | 7.23% | 0.27% | 2.43% | 13.59% | 16.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.23% | 0.27% | 2.43% | 13.59% | 16.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.23% | 0.27% | 2.43% | 13.59% | 16.08% |
| EBIT | 10.13% | 4.31% | 5.81% | 1.49% | 2.69% |
| EBITDA | 10.30% | 4.47% | 6.12% | 1.54% | 2.83% |
| EPS Basic | 27.27% | 15.31% | 25.89% | 48.45% | 56.29% |
| Normalized Basic EPS | 27.27% | 15.32% | 25.89% | 37.21% | 48.38% |
| EPS Diluted | 27.27% | 15.31% | 25.89% | 48.45% | 56.29% |
| Normalized Diluted EPS | 27.27% | 15.32% | 25.89% | 37.21% | 48.38% |
| Average Basic Shares Outstanding | 43.08% | 24.96% | 19.93% | 42.28% | 74.67% |
| Average Diluted Shares Outstanding | 43.08% | 24.96% | 19.93% | 42.28% | 74.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |